About the Journal
Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (E-ISSN: 2442-8744) (p-ISSN: 2442-7284), is an open access journal (print and e-journal) focusing on the scientific works in the field of Pharmacy and Pharmaceutical Science. The articles of this journal are published every six months, that is March and October (2 issues per year). This journal is developed by Department of Pharmacy, Faculty of Mathematics and Natural Science, Tadulako University and has been identified in Crossref with the DOI Number : 10.22487/j24428744. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) has been accredited by Kemenristekdikti as Sinta 3 starting from Volume 5 No 1 2019.
Focus and Scope
Focus and Scope of Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) is as follow : Pharmaceutical Chemistry, Pharmaceutical Technology, Pharmacology and Toxicology, Pharmacognosy and Phytochemistry, Pharmaceutical Microbiology and Biotechnology, Community and Clinical Pharmacy.
Peer Review Process
Submitted papers are evaluated first by editor for contribution, originality, relevance, and presentation. The Editor will then distribute the papers to two reviewers. The time for this process is in 60 to 90 days. Plagiarism detection of articles in this journal is carried out by using plagiarismcheckerx.com (Web Checker)
The kind of review is Single Blind Peer-review
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (E-ISSN: 2442-8744) is a peer-reviewed journal published by Department of Pharmacy, Tadulako University. This statement clarifies ethical behaviour of all parties involved in the act of publishing an article in this journal, including the author, the chief editor, the Editorial Board, the peer-reviewer and the publisher. This statement is based on COPE’s Best Practice Guidelines for Journal Editors.
Ethical Guideline for Journal Publication
The publication of an article in a peer-reviewed Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) is an essential building block in the development of a coherent and respected network of knowledge. It is a direct reflection of the quality of the work of the authors and the institutions that support them. Peer-reviewed articles support and embody the scientific method. It is therefore important to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editor, the peer reviewer, the publisher and the society.
Department of Pharmacy, Tadulako University as publisher of Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) takes its duties of guardianship over all stages of publishing extremely seriously and we recognize our ethical and other responsibilities. We are committed to ensuring that advertising, reprint or other commercial revenue has no impact or influence on editorial decisions. In addition, the Department of Pharmacy, Tadulako University and Editorial Board will assist in communications with other journals and/or publishers where this is useful and necessary.
The editor of the Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) is responsible for deciding which of the articles submitted to the journal should be published. The validation of the work in question and its importance to researchers and readers must always drive such decisions. The editors may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editors may confer with other editors or reviewers in making this decision.
An editor at any time evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.
The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.
Disclosure and conflicts of interest
Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author.
Duties of Reviewers
Contribution to Editorial Decisions
Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper.
Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.
Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.
Standards of Objectivity
Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.
Acknowledgement of Sources
Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.
Disclosure and Conflict of Interest
Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.
Duties of Authors
Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behaviour and are unacceptable.
Data Access and Retention
Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.
Originality and Plagiarism
The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.
Multiple, Redundant or Concurrent Publication
An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behaviour and is unacceptable.
Acknowledgement of Sources
Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work.
Authorship of the Paper
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.
Hazards and Human or Animal Subjects
If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript.
Disclosure and Conflicts of Interest
All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.
Fundamental errors in published works
When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.
Article Processing Charge
This journal charges the following author fees:
- Article Submission: 0.00 (IDR)
- Review : 0.00 (IDR)
- Publication process: 500.000 (IDR)
Editor will inform by email on the decision of submitted manuscript(s) within 4-8 weeks of submission following the acceptance of the manuscript.
This journal publish article twice a year on March and October
Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) adalah jurnal ilmiah yang diterbitkan oleh Jurusan Farmasi, FMIPA, Universitas Tadulako, Palu. Jurnal ini diinisiasi pembentukannya oleh ketua jurusan Farmasi saat itu, Syariful Anam, M.Si, Apt., dengan membentuk tim Panitia yang diketuai oleh Ibu Alwiyah Mukaddas, M.Si, Apt. Jurnal ini mulai menerbitkan artikel ilmiah pertamakali pada edisi Maret 2015. Pada awalnya, jurnal ini hanya sebagai wadah bagi para dosen dilingkungan FMIPA UNTAD untuk mempublikasikan hasil penelitiannya yang merupakan hasil penelitian dari mahasiswa program Sarjana (S1). Editor in Chief Jurnal Farmasi Galenika pertamakali dijabat oleh Ibu Alwiyah Mukaddas, M.Si, Apt.
Setelah dua tahun penerbitan (4 edisi), Jurnal ini kemudian berganti kepengurusan. Mulai tahun 2017, Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) mempunyai Editor in Chief yang baru, yaitu M. Sulaiman Zubair, PhD, Apt
Dengan semangat untuk memperbaiki jurnal ke arah yang lebih baik dan untuk mempersiapkan jurnal untuk dapat menjadi Jurnal Nasional Terakreditasi dan Jurnal Internasional terindeks Scopus, beberapa kegiatan telah dilakukan. Salah satunya adalah mendapatkan bantuan TataKelola Jurnal Ilmiah Elektronik dari Kemenristekdikti untuk Tahun Anggaran 2017. Dengan bantuan ini, beberapa kegiatan telah dilakukan guna memperbaiki dan meningkatkan mutu Jurnal, seperti : Pengembangan website, pendaftaran jurnal ke DOAJ, penggunaan indeksasi nomor DOI untuk setiap makalah per edisi terbit mulai edisi Maret 2017, lokakarya dewan editor, pelatihan penulisan artikel ilmiah dan pelatihan submit dan review online.
Salah satu perbaikan yang dilakukan juga adalah mengubah tampilan template jurnal farmasi galenika. Mulai edisi Oktober 2017, template format penulisan jurnal telah mengalami perubahan.
Jurnal farmasi galenika telah terakreditasi sinta peringkat 4. Terhitung Volume 5 No 1 tahun 2019, jurnal farmasi galenika naik peringkat ke Sinta 3
Pada tahun 2020, Jurnal Farmasi Galenika telah mengembangakan sistem OJS nya menjadi OJS 3, dengan alamat url yang baru.